# Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients

Study · id `cardio:ct-nct06717685` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06717685](<https://clinicaltrials.gov/study/NCT06717685>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06717685

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT06717685. Randomized; single masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2025-01-27 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT06717685, source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)
- Started: 2024-10-28 (actual) (ClinicalTrials.gov record NCT06717685, source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)
- Primary completion: 2025-01-27 (anticipated) (ClinicalTrials.gov record NCT06717685, source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)
- Completion: 2025-02-03 (anticipated) (ClinicalTrials.gov record NCT06717685, source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT06717685, source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06717685-2024-12-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
- Condition: Supraventricular Tachycardia (SVtach)
- Intervention (Drug): Adenosine
- Intervention (Drug): Verapamil Injection
- Lead sponsor: Rashid Latif Medical College
- Lead sponsor class: OTHER
- Collaborator: Punjab Institute of Cardology
- Collaborator class: OTHER
- Collaborator: Himmel Pharmaceutical private limited, Pakistan
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)

## Provenance

Content hash: cf438be03beac23d0c445a655e3d9a9961a1c80e8793f84209071e9c81415f30
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
